|
ZNF718 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94860000005226E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.381000E-04 |
| Normal-vs-Stage2 |
1.80542000000061E-05 |
| Normal-vs-Stage3 |
6.88550000016441E-07 |
| Normal-vs-Stage4 |
1.82092999999606E-05 |
| Stage1-vs-Stage2 |
7.936000E-02 |
| Stage1-vs-Stage3 |
5.643800E-02 |
| Stage1-vs-Stage4 |
1.046210E-01 |
| Stage2-vs-Stage3 |
8.178200E-01 |
| Stage2-vs-Stage4 |
8.410200E-01 |
| Stage3-vs-Stage4 |
9.881400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.73710000015571E-07 |
| Normal-vs-AfricanAmerican |
5.382800E-01 |
| Normal-vs-Asian |
2.00559999999905E-05 |
| Caucasian-vs-AfricanAmerican |
6.841700E-03 |
| Caucasian-vs-Asian |
3.208000E-01 |
| AfricanAmerican-vs-Asian |
3.883200E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24609999985204E-07 |
| Normal-vs-Female |
6.27659999999919E-05 |
| Male-vs-Female |
6.078200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.063700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.43450000001222E-07 |
| Normal-vs-Age(61-80Yrs) |
2.24669999999705E-05 |
| Normal-vs-Age(81-100Yrs) |
8.363600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.765900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.118400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.243200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.124800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.452400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.394400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.045200E-01 |
| Classical-VS-Follicular |
7.471000E-01 |
| Classical-VS-Other |
3.085800E-01 |
| Classical-VS-Normal |
3.7151000000013E-05 |
| Tall-VS-Follicular |
6.852800E-01 |
| Tall-VS-Other |
4.603000E-01 |
| Tall-VS-Normal |
6.161000E-04 |
| Follicular-VS-Other |
4.593600E-01 |
| Follicular-VS-Normal |
7.793700E-04 |
| Other-VS-Normal |
1.006490E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61966999999708E-05 |
| Normal-vs-N1 |
4.14409999982546E-07 |
| N0-vs-N1 |
1.120250E-01 |
|
|
